Pralatrexate for refractory mycosis fungoides in two Japanese patients.


Journal

The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545

Informations de publication

Date de publication:
May 2021
Historique:
revised: 21 12 2020
received: 25 11 2019
accepted: 22 12 2020
pubmed: 18 1 2021
medline: 15 5 2021
entrez: 17 1 2021
Statut: ppublish

Résumé

Pralatrexate has been approved for the treatment of relapsed/refractory peripheral T cell lymphomas. Studies in the U.S. also support the clinical efficacy of pralatrexate to treat advanced-stage cutaneous T-cell lymphomas, but outcomes in Japanese patients have not yet been reported. We herein describe two Japanese patients with heavily-pretreated relapsed/refractory mycosis fungoides that were successfully controlled by pralatrexate.

Identifiants

pubmed: 33454985
doi: 10.1111/1346-8138.15761
pmc: PMC8248132
doi:

Substances chimiques

10-propargyl-10-deazaaminopterin 0
Aminopterin JYB41CTM2Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-671

Subventions

Organisme : Mundipharma International

Informations de copyright

© 2021 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.

Références

Blood. 2018 Jan 25;131(4):397-407
pubmed: 29141948
Case Rep Oncol. 2019 Jul 16;12(2):529-536
pubmed: 31427947
J Clin Oncol. 2011 Mar 20;29(9):1182-9
pubmed: 21245435
Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):238-43
pubmed: 22542448
J Clin Oncol. 2011 Jun 20;29(18):2598-607
pubmed: 21576639
Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e445-e447
pubmed: 30181105
Leuk Lymphoma. 2003 Jun;44(6):1027-35
pubmed: 12854905
Clin Cancer Res. 2017 Jul 15;23(14):3552-3556
pubmed: 28167509
Curr Oncol Rep. 2018 Mar 23;20(4):32
pubmed: 29572582
Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):297-304
pubmed: 24589156
J Clin Oncol. 2010 Nov 1;28(31):4730-9
pubmed: 20855822
Dermatol Clin. 2015 Oct;33(4):747-55
pubmed: 26433846
Cancer Sci. 2017 Oct;108(10):2061-2068
pubmed: 28771889
J Dermatol. 2013 Jan;40(1):2-14
pubmed: 22900999
Blood. 2012 May 3;119(18):4115-22
pubmed: 22394596

Auteurs

Mika Teraishi (M)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Tokuko Oguro (T)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Ema Kusume (E)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Haruka Kobashi (H)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Hozumi Sano (H)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Ai Fujioka (A)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Mayuko Yamamoto (M)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Hideki Nakajima (H)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Shigetoshi Sano (S)

Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH